Costa Rica vs Upper-middle income (World Bank): Hypertension effective treatment coverage (controlled hypertension)
Costa Rica
49.7%
in 2019
Upper-middle income (World Bank)
18.6%
in 2019
Costa Rica rank
4th
Upper-middle income (World Bank) rank
5th
Hypertension effective treatment coverage (controlled hypertension) over time
- Costa Rica
- Upper-middle income (World Bank)
How they compare
Costa Rica currently reports 49.7% against 18.6% in Upper-middle income (World Bank), a difference of 31.1%.
That makes Costa Rica's figure about 2.7 times Upper-middle income (World Bank)'s.
Across all 30 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 4th and Upper-middle income (World Bank) ranks 5th of 193 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Upper-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 11.7% | 4.6% | 7.1% | Costa Rica |
| 2000s | 21.4% | 9.7% | 11.7% | Costa Rica |
| 2010s | 41.1% | 16.4% | 24.7% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Costa Rica or Upper-middle income (World Bank)?
- Costa Rica, at 49.7% against 18.6% in Upper-middle income (World Bank) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Costa Rica and Upper-middle income (World Bank)?
- 31.1%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Upper-middle income (World Bank)?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and Upper-middle income (World Bank) rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Costa Rica ranks 4th and Upper-middle income (World Bank) ranks 5th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.